AI Visibility Scorecard
abouttecelra.com · Healthcare
Borderline visible. AI bots can crawl TECELRA (afamitresgene autoleucel) Cell Therapy, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 1 times
Claude
#656,459 of 919,067 in Healthcare for AI visibility
4
AEO Visibility
iBorderline · 4.2/10
0
Muse Index Score
iAI agent readiness
Not agent-ready · 0/100
0
AI Adoption
iNone detected · 0/100
from our crawl and measurement
TECELRA (afamitresgene autoleucel) Cell Therapy describes itself simply: "Cell therapy is a different kind of treatment approach sometimes used for cancer. Explore the kinds of cell therapy and how they work with your body." When AI engines look at it, they find little to work with. It scores 4.2 out of 10.
Our crawl found a readable heading structure. It is missing structured data describing the business, an llms.txt file and a sitemap.
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Good
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Fair
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Strong
Sitemaps and entity links AI can follow.
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 4.2/10, TECELRA (afamitresgene autoleucel) Cell Therapy is crawlable but under-signaled - fixable, and the signals above are where to start.
What is TECELRA?
TECELRA is a medicine, called a genetically modified autologous T cell immunotherapy, that is used to treat synovial sarcoma. It is used when other kinds of treatment do not work. TECELRA is different from other cancer medicines because it is made from your own white blood cells that are made to recognize and attack your cancer cells. Your healthcare provider will perform tests to see if TECELRA is right for you.
Is this your brand?
The exact fixes for TECELRA (afamitresgene autoleucel) Cell Therapy
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for TECELRA (afamitresgene autoleucel) Cell Therapy.
Scored by Engagemii on August 8, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/abouttecelra
Cite this score: Engagemii (2026). "AEO Score for TECELRA (afamitresgene autoleucel) Cell Therapy." Retrieved from https://engagemii.com/aeo/brands/abouttecelra
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform